"Parasympatholytics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
| Descriptor ID |
D010276
|
| MeSH Number(s) |
D27.505.696.663.050.650
|
| Concept/Terms |
Parasympatholytics- Parasympatholytics
- Parasympatholytic Drugs
- Drugs, Parasympatholytic
- Parasympathetic-Blocking Agents
- Agents, Parasympathetic-Blocking
- Parasympathetic Blocking Agents
- Parasympatholytic Agents
- Agents, Parasympatholytic
Parasympatholytic Effect- Parasympatholytic Effect
- Effect, Parasympatholytic
- Parasympatholytic Effects
- Effects, Parasympatholytic
Antispasmodic Effect- Antispasmodic Effect
- Effect, Antispasmodic
- Antispasmodic Effects
- Effects, Antispasmodic
Antispasmodics- Antispasmodics
- Antispasmodic Drugs
- Drugs, Antispasmodic
- Spasmolytics
- Antispasmodic Agents
- Agents, Antispasmodic
|
Below are MeSH descriptors whose meaning is more general than "Parasympatholytics".
Below are MeSH descriptors whose meaning is more specific than "Parasympatholytics".
This graph shows the total number of publications written about "Parasympatholytics" by people in this website by year, and whether "Parasympatholytics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parasympatholytics" by people in Profiles.
-
Gherghina FL, Tica AA, Deliu E, Abood ME, Brailoiu GC, Brailoiu E. Effects of VPAC1 activation in nucleus ambiguus neurons. Brain Res. 2017 02 15; 1657:297-303.
-
Maser RE, Lenhard MJ, Kolm P, Edwards DG. Direct renin inhibition improves parasympathetic function in diabetes. Diabetes Obes Metab. 2013 Jan; 15(1):28-34.
-
Dalakas MC. Advances in the pathogenesis and treatment of patients with stiff person syndrome. Curr Neurol Neurosci Rep. 2008 Jan; 8(1):48-55.
-
Rovner BW, David A, Lucas-Blaustein MJ, Conklin B, Filipp L, Tune L. Self-care capacity and anticholinergic drug levels in nursing home patients. Am J Psychiatry. 1988 Jan; 145(1):107-9.